WorldQuant Millennium Advisors
GILD icon

WorldQuant Millennium Advisors’s Gilead Sciences GILD Stock Holding History

WorldQuant Millennium Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$156M Buy
1,235,893
+806,858
+188% +$106M 0.54% 46
2026
Q1 		$59.8M Buy
429,035
+223,470
+109% +$31.3M 0.23% 114
2025
Q4 		$25.2M Sell
205,565
-1,022,080
-83% -$124M 0.1% 199
2025
Q3 		$136M Buy
1,227,645
+450,397
+58% +$51.2M 0.59% 46
2025
Q2 		$86.2M Buy
+777,248
New +$82.7M 0.43% 61
2024
Q4 		– Sell
-135,420
Closed -$11.4M – 462
2024
Q3 		$11.4M Sell
135,420
-775,397
-85% -$59.2M 0.08% 220
2024
Q2 		$62.5M Buy
910,817
+837,368
+1,140% +$55.9M 0.57% 38
2024
Q1 		$5.38M Hold
73,449
– – 0.07% 240
2023
Q4 		$5.95M Sell
73,449
-41,970
-36% -$3.27M 0.08% 213
2023
Q3 		$8.65M Buy
115,419
+15,672
+16% +$1.21M 0.13% 193
2023
Q2 		$7.69M Sell
99,747
-271,429
-73% -$21.6M 0.13% 205
2023
Q1 		$30.8M Buy
371,176
+90,182
+32% +$7.47M 0.57% 53
2022
Q4 		$24.1M Buy
280,994
+26,768
+11% +$2.12M 0.55% 59
2022
Q3 		$15.7M Buy
254,226
+177,815
+233% +$11.2M 0.38% 86
2022
Q2 		$4.72M Buy
76,411
+4,579
+6% +$284K 0.14% 193
2022
Q1 		$4.27M Sell
71,832
-11,616
-14% -$743K 0.1% 217
2021
Q4 		$6.06M Sell
83,448
-2,240
-3% -$154K 0.12% 198
2021
Q3 		$5.99M Sell
85,688
-4,620
-5% -$325K 0.13% 194
2021
Q2 		$6.22M Sell
90,308
-18,389
-17% -$1.23M 0.14% 181
2021
Q1 		$7.03M Hold
108,697
– – 0.15% 203
2020
Q4 		$6.33M Hold
108,697
– – 0.14% 210
2020
Q3 		$6.87M Buy
108,697
+1,536
+1% +$107K 0.16% 181
2020
Q2 		$8.24M Sell
107,161
-27,773
-21% -$2.13M 0.19% 160
2020
Q1 		$10.1M Sell
134,934
-269,246
-67% -$18.6M 0.25% 130
2019
Q4 		$26.3M Sell
404,180
-27,158
-6% -$1.77M 0.5% 71
2019
Q3 		$27.3M Sell
431,338
-165,110
-28% -$10.8M 0.53% 64
2019
Q2 		$40.3M Buy
596,448
+97,649
+20% +$6.42M 0.77% 40
2019
Q1 		$32.4M Buy
+498,799
New +$33.2M 0.77% 39

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WorldQuant Millennium Advisors's GILD Position: Q2 2026 in Review

WorldQuant Millennium Advisors increased its Gilead Sciences (GILD) stake by 188% in Q2 2026, buying an estimated $106M and bringing the position to 1,235,893 shares worth $156M. The position accounts for 0.54% of the portfolio, ranked #46.

WorldQuant Millennium Advisors first reported a position in GILD in Q1 2019 and has held it in 28 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • WorldQuant Millennium Advisors held 1,235,893 shares of Gilead Sciences worth $156M as of Q2 2026.
  • WorldQuant Millennium Advisors bought 806,858 Gilead Sciences shares in Q2 2026, an estimated $106M.
  • Gilead Sciences made up 0.54% of WorldQuant Millennium Advisors's portfolio in Q2 2026, its #46 holding.
  • WorldQuant Millennium Advisors first reported a position in Gilead Sciences in Q1 2019 and has held it in 28 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.